Filariasis Clinical Trial 2004-105

Diethylcarbamazine Citrate (DEC) For Treatment Of Filariasis

The purpose of this study is to provide diethylcarbamazine citrate (DEC) to U.S.- licensed physicians for treating individual patients who have certain filarial diseases.

Disease/Condition: Filariasis

Department: Infectious Disease

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734

Principal Investigator(s): Winnie W Ooi
Study Coordinator(s): Deborah Gannon
Trial Phase: Sponsor Initiated Study Observational